The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPERE.L Regulatory News (PERE)

  • There is currently no data for PERE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Revised Subscription

24 Apr 2020 07:00

RNS Number : 7212K
Pembridge Resources plc
24 April 2020
 

 

24 April 2020

 

Revised Subscription

London, United Kingdom - Pembridge Resources plc (LSE: PERE) ("Pembridge" or the "Company") announces a revision to the Subscription announced on Monday 20 April 2020.

The Company has become aware that it may not issue 19,183,179 new ordinary shares to raise £633,000 under the original subscription as it exceeds the amount permissible under the Listing Rules of the FCA despite the Company being able to issue the shares under existing authorities granted by shareholders. The maximum amount permitted under the Listing Rules for standard listed companies is 20% of its current issued share capital.

With regard to the issued share capital, the Company has recently cancelled 5,489,453 ordinary shares following matters concerning bonus shares issued at the time of the IPO. The revised issued share capital of the Company is now 63,231,494 ordinary shares of 1p. Also, the Company has provided a sufficient balance for certain options and warrants to be exercised if required. In order to mitigate the amount of share capital headroom allocated to options and warrants the directors have agreed to surrender their options as follows:

Director

Number of share options surrendered

Gati Al-Jebouri

3,015,000

Frank McAllister

535,000

Guy Le Bel

535,000

 

Therefore, the Company intends to issue 11,175,499 new ordinary shares resulting in a revised subscription of £368,000 ("Subscription Shares") at the same price of 3.3p. The balance of 8,007,680 excess shares issued and allotted under the original subscription have been cancelled.

Director Subscriptions

Director

Current Holding

Subscription Shares

% Holding following Subscription and Admission*

Gati Al-Jebouri

11,667,496

3,751,258

20.7%

Frank McAllister

3,451,419

1,212,121

6.3%

*issued share capital of 74,406,993

Application to LSE

The Company intends to issue the Subscription Shares under its existing authorities and an application has been made to the London Stock Exchange for the Subscription Shares, which rank pari passu with the Company's existing issued ordinary shares, to be admitted to trading on the LSE. Dealings are expected to commence from 8.00 a.m. on 29 April 2020 ("Admission"). 

The Company's issued ordinary share capital following Admission will be 74,406,993 ordinary shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

Gati Al-Jebouri, Chief Executive Officer and Chairman of the Board of Pembridge said:

"We have had to adjust the size of Placing to ensure we are compliant with the prospectus regulation rules (including the exemption under PRR 1.2.4, Article 1 (5)(a)). Certain Directors have also agreed to surrender their options, thereby maximising the amount of capital that could be raised in the Placing. Despite the reduced size the Company remains in a stable financial position to meet any envisaged working capital requirements from existing cash resources and as yet undrawn loans."

 

ENDS

 

NOTES TO EDITORS

About Pembridge Resources plc

Pembridge is a mining company that is listed on the standard segment of the Official List of the FCA and trading on the main market for listed securities of London Stock Exchange plc. Pembridge has an investment in Minto Explorations Ltd, a British Columbia incorporated business operating the Minto mine in Yukon, Canada.

Enquiries:

 

Pembridge Resources plc: +44 (0)20 7917 2968

Gati Al-Jebouri, Chief Executive Officer and Chairman of the Board

David James, Chief Financial Officer

 

Brandon Hill Capital - United Kingdom: +44 (0)20 3463 5016

Jonathan Evans

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAPLDADXEEFA
Date   Source Headline
15th May 20174:41 pmRNSPosting of Notice of AGM
12th May 20177:00 amRNSResults for the Year Ended 31 December 2016
3rd May 20175:06 pmRNSUpdate on AIM Rule 15 status
18th Apr 20177:00 amRNSSenior Management Appointment
11th Apr 20178:28 amRNSTR-1: Notification of major interest in shares
10th Apr 20177:00 amRNSAppointment of Shard Capital Partners as Broker
10th Apr 20177:00 amRNSSenior Management Appointment
7th Apr 201711:20 amRNSChange of Name, Registered Address and Update
28th Mar 20175:59 pmRNSTR-1: Notification of Major Interest in Shares
23rd Mar 20179:34 amRNSChange of Name
16th Mar 20173:51 pmRNSHolding in Company
9th Mar 20177:00 amRNSSenior Management Appointment
2nd Mar 20178:26 amRNSAppointment of Frank McAllister to Advisory Board
2nd Mar 20177:00 amRNSChange of Name and Notice of GM
28th Feb 20178:40 amRNSAppointment of Guy Le Bel to Advisory Board
20th Feb 20178:11 amRNSNotifiable Holding
17th Feb 20171:36 pmRNSBoard Changes
8th Feb 201710:00 amRNSInvestment Agreement - USA Lithium
1st Feb 20177:00 amRNSInvestment Agreement Botswana
26th Jan 20178:04 amRNSChange of Adviser
11th Jan 20178:17 amRNSCompletion of In-Specie Distribution Process
30th Dec 20168:53 amRNSStrategic and Operational Update
29th Dec 201610:00 amRNSChange of Registered Office
19th Dec 201610:06 amRNSDirector Share Purchase
14th Dec 20161:11 pmRNSResult of GM
25th Nov 20169:14 amRNSNotice of GM
21st Nov 201612:38 pmRNSFurther re Capital Reorganisation
21st Nov 20169:22 amRNSCapital Reorganisation
16th Nov 201610:18 amRNSShare Price Movement
11th Aug 201612:34 pmRNSShare Price Movement
27th Jul 201611:12 amRNSHalf-year Report
7th Jul 20163:16 pmRNSResult of AGM
14th Jun 20162:57 pmRNSNotice of AGM
17th May 201611:03 amRNSAnnual Financial Report
9th May 20167:00 amRNSFinal Results
27th Apr 201611:20 amRNSChange of Address
16th Nov 201511:15 amRNSLoan from HK ECE and Directorate Change
3rd Sep 20157:00 amRNSInterim Results
9th Jun 20151:00 pmRNSResult of AGM
6th May 20159:34 amRNSNotice of AGM and Posting of Annual Report
13th Apr 20157:00 amRNSChange of Address
4th Mar 20157:00 amRNSFinal Results
10th Sep 20147:00 amRNSDirectorate Changes
10th Sep 20147:00 amRNSInterim Results
17th Jul 20146:00 pmRNSDirectorate Change
10th Jun 201412:53 pmRNSResult of AGM
3rd Jun 20147:00 amRNSNotice of AGM and Posting of Annual Report
27th May 20147:00 amRNSBerg Aukas Pre Feasibility Study Results
14th Mar 20147:00 amRNSFinal Results
29th Jan 20147:00 amRNSUpdate on Feasibility Study

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.